Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001321225 | SCV001512047 | uncertain significance | Immunodeficiency due to CD25 deficiency | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with arginine at codon 42 of the IL2RA protein (p.Lys42Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. This variant is present in population databases (rs142016545, ExAC 0.06%). This variant has not been reported in the literature in individuals affected with IL2RA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002476506 | SCV002799774 | uncertain significance | Type 1 diabetes mellitus 10; Immunodeficiency due to CD25 deficiency | 2022-04-05 | criteria provided, single submitter | clinical testing |